Literature DB >> 17270454

Soluble adhesion molecules and angiotensin-converting enzyme in dementia.

Henrietta M Nielsen1, Elisabet Londos, Lennart Minthon, Sabina M Janciauskiene.   

Abstract

We aimed to determine plasma and cerebrospinal fluid (CSF) levels of angiotensin-converting enzyme (ACE) and the soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and platelet endothelial cell adhesion molecule-1 (sPECAM-1) as surrogate markers for endothelial cell activation in clinically diagnosed patients with Alzheimer's disease (AD, n=260), dementia with Lewy bodies (DLB, n=39) and non-demented controls (n=34). Plasma sICAM-1 and sPECAM-1 were higher and CSF sVCAM-1 were lower in AD and DLB patients than in controls (p<0.001). DLB patients had higher CSF sICAM-1, but lower CSF sVCAM-1 (p<0.001). No difference in ACE levels was found between the dementia groups and controls. In controls and AD patients CSF sICAM and sVCAM-1 strongly correlated with each other and with blood barrier permeability whereas in DLB group these correlations were weaker. The observed patterns in adhesion molecules may reflect distinctions in the pathophysiological basis of their generation in dementia patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270454     DOI: 10.1016/j.nbd.2006.11.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

1.  Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

Authors:  Scott Miners; Emma Ashby; Shabnam Baig; Rachel Harrison; Hannah Tayler; Elizabeth Speedy; Jonathan A Prince; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2009-01-18       Impact factor: 4.060

Review 2.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

Review 3.  Cerebrospinal fluid and blood biomarkers in Alzheimer's disease.

Authors:  Christian Humpel; Tanja Hochstrasser
Journal:  World J Psychiatry       Date:  2011-12-31

Review 4.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

5.  Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.

Authors:  Malin Wennström; Henrietta M Nielsen; Funda Orhan; Elisabet Londos; Lennart Minthon; Sophie Erhardt
Journal:  Int J Tryptophan Res       Date:  2014-04-28

6.  Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.

Authors:  Katarina Nägga; Carina Wattmo; Yi Zhang; Lars-Olof Wahlund; Sebastian Palmqvist
Journal:  Alzheimers Res Ther       Date:  2014-07-07       Impact factor: 6.982

7.  Clinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.

Authors:  Ming-Kung Wu; Yan-Ting Lu; Chi-Wei Huang; Pin-Hsuan Lin; Nai-Ching Chen; Chun-Chung Lui; Wen-Neng Chang; Chen-Chang Lee; Ya-Ting Chang; Sz-Fan Chen; Chiung-Chih Chang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

8.  Angiotensins and Alzheimer's disease: a bench to bedside overview.

Authors:  Patrick G Kehoe
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

9.  Alzheimer disease and platelets: how's that relevant.

Authors:  Silvia Catricala; Mauro Torti; Giovanni Ricevuti
Journal:  Immun Ageing       Date:  2012-09-17       Impact factor: 6.400

Review 10.  Contribution of blood platelets to vascular pathology in Alzheimer's disease.

Authors:  Wei Zhang; Wei Huang; Fang Jing
Journal:  J Blood Med       Date:  2013-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.